Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_assertion type Assertion NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_head.
- NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_assertion description "[We show, in both human pancreatic adenocarcinoma and a murine pancreatic tumor model (Pan02), that tumor cells produce increased levels of ligands for the CCR5 chemokine receptor and, reciprocally, that CD4(+) Foxp3(+) Tregs, compared with CD4(+) Foxp3(-) effector T cells, preferentially express CCR5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_provenance.
- NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_assertion evidence source_evidence_literature NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_provenance.
- NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_assertion SIO_000772 19155524 NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_provenance.
- NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_assertion wasDerivedFrom befree-20140225 NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_provenance.
- NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_assertion wasGeneratedBy ECO_0000203 NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_provenance.